Minqi Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Minqi Li has a total of 281 co-authors. Here are the top co-authors by number of shared publications:
Hongrui Liu
39 shared publicationsNorio Amizuka
Ultrastructure of Hard Tissues, Faculty of Dental Medicine Hokkaido University Sapporo Japan
27 shared publicationsWei Feng
Department of Bone Metabolism, School of Stomatology Shandong University, Shandong Provincial Key Laboratory of Oral Tissue Regeneration, Jinan, China
25 shared publicationsJuan Du
Department of Bone Metabolism, School of Stomatology Shandong University, Shandong Provincial Key Laboratory of Oral Tissue Regeneration, Jinan, China
23 shared publicationsPanpan Yang
Department of Dental Implant, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
22 shared publications- Hongrui Liu
Department of Bone Metabolism, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University & Shandong Key Laboratory of Oral Tissue Regeneration & Shandong Engineering Research Center of Dental Materials and Oral Tissue Regeneration & Shandong Provincial Clinical Research Center for Oral Diseases, Jinan, China
21 shared publications
Latest Publications
- Open Access
- 16 October 2026
- Published by Elsevier in International Dental Journal
- Vol. 76 (6)
TXNIP/PINK1 Mitophagy Axis Promotes Th17 and Bone Loss in Diabetic Periodontitis
- 16 October 2026
- Published by Elsevier in International Dental Journal
- Vol. 76 (6)
Open AccessTXNIP/PINK1 Mitophagy Axis Promotes Th17 and Bone Loss in Diabetic Periodontitis
- Open Access
- 21 September 2026
- Published by Springer Nature in Cell Death Discovery
Osteocyte necroptosis drives cortical bone resorption via osteocytic osteolysis in glucocorticoid-induced osteoporosis
Glucocorticoid-induced osteoporosis (GIOP) is characterized by progressive cortical bone fragility accompanied by osteocyte lacunar enlargement and peri-lacunar osteolysis. However, whether these microstructural alterations arise from a specific cell death program remains unclear. Here, we demonstrate that glucocorticoids activate STIM1-ORAI1-dependent store-operated calcium entry (SOCE) in osteocytes, thereby promoting NFATc1 nuclear translocation. Activated NFATc1 induces mitophagy arrest, accumulation of dysfunctional mitochondria, and a burst of mitochondrial reactive oxygen species (mtROS), which subsequently triggers RIPK1/RIPK3/MLKL-mediated necroptosis. In a murine GIOP model, pharmacological inhibition of SOCE and NFATc1 knockdown each abrogated osteocyte necroptosis, alleviated cortical osteolysis, and preserved bone mechanical properties. Osteocyte-specific deletion of MLKL phenocopied these protective effects, further confirming necroptosis as the terminal effector of this process. Collectively, these findings identify the SOCE–NFATc1–mitophagy–mtROS axis as a critical signaling pathway linking calcium dysregulation to oxidative injury in osteocytes. Targeting this pathway disrupts the redox vulnerability underlying glucocorticoid-induced cortical bone loss and provides a therapeutic strategy for preserving skeletal integrity during long-term glucocorticoid therapy.
- 21 September 2026
- Published by Springer Nature in Cell Death Discovery
Open AccessOsteocyte necroptosis drives cortical bone resorption via osteocytic osteolysis in glucocorticoid-induced osteoporosis
Glucocorticoid-induced osteoporosis (GIOP) is characterized by progressive cortical bone fragility accompanied by osteocyte lacunar enlargement and peri-lacunar osteolysis. However, whether these microstructural alterations arise from a specific cell death program remains unclear. Here, we demonstrate that glucocorticoids activate STIM1-ORAI1-dependent store-operated calcium entry (SOCE) in osteocytes, thereby promoting NFATc1 nuclear translocation. Activated NFATc1 induces mitophagy arrest, accumulation of dysfunctional mitochondria, and a burst of mitochondrial reactive oxygen species (mtROS), which subsequently triggers RIPK1/RIPK3/MLKL-mediated necroptosis. In a murine GIOP model, pharmacological inhibition of SOCE and NFATc1 knockdown each abrogated osteocyte necroptosis, alleviated cortical osteolysis, and preserved bone mechanical properties. Osteocyte-specific deletion of MLKL phenocopied these protective effects, further confirming necroptosis as the terminal effector of this process. Collectively, these findings identify the SOCE–NFATc1–mitophagy–mtROS axis as a critical signaling pathway linking calcium dysregulation to oxidative injury in osteocytes. Targeting this pathway disrupts the redox vulnerability underlying glucocorticoid-induced cortical bone loss and provides a therapeutic strategy for preserving skeletal integrity during long-term glucocorticoid therapy.
- 26 June 2026
- Published by Elsevier in Cellular Signalling
- Vol. 146, 112694
O-GlcNAcylation-mediated glycolytic reprogramming of CD4+ T cells contributes to type H vessel impairment in diabetic osteoporosis
- 26 June 2026
- Published by Elsevier in Cellular Signalling
- Vol. 146, 112694
O-GlcNAcylation-mediated glycolytic reprogramming of CD4+ T cells contributes to type H vessel impairment in diabetic osteoporosis
- Open Access
- 18 May 2026
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (21) , 30550-30560
IGF2BP2 Promotes Oral Squamous Cell Carcinoma Progression and Is Associated with MAPK Signaling and Macrophage-Related Immune Features
Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) is an mRNA-binding protein implicated in tumorigenesis across multiple cancer types, but its functional role in oral squamous cell carcinoma (OSCC) remains incompletely understood. In this study, we combined bioinformatic analyses, validation in clinical specimens and cell lines, and functional experiments to investigate the role of IGF2BP2 in OSCC. IGF2BP2 was significantly elevated in OSCC and associated with poor overall survival. This upregulation was further validated in patient tissues and OSCC cell lines by quantitative real-time PCR, Western blot, and immunohistochemistry. IGF2BP2 knockdown markedly suppressed OSCC cell proliferation and migration in vitro and inhibited tumor growth in xenograft models in vivo. In parallel, IGF2BP2 depletion resulted in reduced phosphorylation of ERK and p38, supporting an association between IGF2BP2 and MAPK signaling activity in OSCC. In addition, immune-related pathway enrichment and immune infiltration analyses further suggested links between IGF2BP2 and the OSCC tumor immune microenvironment. Flow cytometric analysis of xenograft tumors revealed that IGF2BP2 knockdown altered macrophage-related immune features, including a reduced proportion of CD86+ M1-like tumor-associated macrophages. Collectively, these findings support an oncogenic role for IGF2BP2 in OSCC and suggest that IGF2BP2 is associated with MAPK signaling and macrophage-related immune features in OSCC.
- 18 May 2026
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (21) , 30550-30560
Open AccessIGF2BP2 Promotes Oral Squamous Cell Carcinoma Progression and Is Associated with MAPK Signaling and Macrophage-Related Immune Features
Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) is an mRNA-binding protein implicated in tumorigenesis across multiple cancer types, but its functional role in oral squamous cell carcinoma (OSCC) remains incompletely understood. In this study, we combined bioinformatic analyses, validation in clinical specimens and cell lines, and functional experiments to investigate the role of IGF2BP2 in OSCC. IGF2BP2 was significantly elevated in OSCC and associated with poor overall survival. This upregulation was further validated in patient tissues and OSCC cell lines by quantitative real-time PCR, Western blot, and immunohistochemistry. IGF2BP2 knockdown markedly suppressed OSCC cell proliferation and migration in vitro and inhibited tumor growth in xenograft models in vivo. In parallel, IGF2BP2 depletion resulted in reduced phosphorylation of ERK and p38, supporting an association between IGF2BP2 and MAPK signaling activity in OSCC. In addition, immune-related pathway enrichment and immune infiltration analyses further suggested links between IGF2BP2 and the OSCC tumor immune microenvironment. Flow cytometric analysis of xenograft tumors revealed that IGF2BP2 knockdown altered macrophage-related immune features, including a reduced proportion of CD86+ M1-like tumor-associated macrophages. Collectively, these findings support an oncogenic role for IGF2BP2 in OSCC and suggest that IGF2BP2 is associated with MAPK signaling and macrophage-related immune features in OSCC.
- 8 May 2026
- Published by Wiley in Orthodontics & Craniofacial Research
- Vol. 29 (5) , 888-898
Three Data‐Driven Lip Soft‐Tissue Phenotypes and Their Dento‐Skeletal Associations in Orthodontic Patients: An Exploratory Unsupervised Learning Study
Background: Conventional facial diagnosis emphasizes skeletal and dental measures while lip features are assessed piecemeal. We aimed to identify data‐driven lip soft‐tissue phenotypes using unsupervised machine learning and examine their associations with skeletal and dental characteristics. Methods: In a retrospective cross‐sectional study, 10 lip measurements were extracted from standardized lateral cephalometric radiographs. Variables were z ‐score standardized and analysed using k‐means clustering. Of 26 NbClust validation indices, 14 (53.8%) supported a three‐cluster solution. Cluster stability was assessed by bootstrap resampling (B = 100) and 10‐fold cross‐validation. Post hoc feature importance was evaluated using PCA, Random Forest, SVM and XGBoost. A decision tree was trained and evaluated by 10‐fold cross‐validation repeated five times. Associations with craniofacial parameters were examined via within‐class ANOVA, Cramér's V and hierarchical regression. Concordant pairings were defined as Cluster 1–Class I, Cluster 2–Class II and Cluster 3–Class III; all others were classified as discordant. Results: Three phenotypes emerged—Thin‐Straight ( n = 638), Protrusive‐Convex ( n = 644) and Thick‐Concave ( n = 389)—showing broad correspondence with skeletal Classes I, II and III, respectively (Cramér's V = 0.386; overall concordance 52.8%). Lip protrusion and thickness were the primary discriminators (4/4 method consensus for UL_EP_mm, Cm_Sn_Ls, SSD; 3/4 for ULT). Within each skeletal class, all lip variables differed significantly across phenotypes (all p < 0.001; η 2 = 0.10–0.54 for lip variables), and lip phenotype independently predicted incisor inclination beyond skeletal covariates (Δ R 2 adj = 0.058–0.078, p < 0.001). An interpretable decision tree achieved 88.0% cross‐validated accuracy (macro‐F1 = 0.876) for phenotype assignment. Conclusions: Unsupervised learning identified three reproducible lip soft‐tissue phenotypes that complement conventional dentoskeletal description by capturing within‐class soft‐tissue heterogeneity. The framework is exploratory and requires prospective external validation and outcome‐based studies before clinical triage application.
- 8 May 2026
- Published by Wiley in Orthodontics & Craniofacial Research
- Vol. 29 (5) , 888-898
Three Data‐Driven Lip Soft‐Tissue Phenotypes and Their Dento‐Skeletal Associations in Orthodontic Patients: An Exploratory Unsupervised Learning Study
Background: Conventional facial diagnosis emphasizes skeletal and dental measures while lip features are assessed piecemeal. We aimed to identify data‐driven lip soft‐tissue phenotypes using unsupervised machine learning and examine their associations with skeletal and dental characteristics. Methods: In a retrospective cross‐sectional study, 10 lip measurements were extracted from standardized lateral cephalometric radiographs. Variables were z ‐score standardized and analysed using k‐means clustering. Of 26 NbClust validation indices, 14 (53.8%) supported a three‐cluster solution. Cluster stability was assessed by bootstrap resampling (B = 100) and 10‐fold cross‐validation. Post hoc feature importance was evaluated using PCA, Random Forest, SVM and XGBoost. A decision tree was trained and evaluated by 10‐fold cross‐validation repeated five times. Associations with craniofacial parameters were examined via within‐class ANOVA, Cramér's V and hierarchical regression. Concordant pairings were defined as Cluster 1–Class I, Cluster 2–Class II and Cluster 3–Class III; all others were classified as discordant. Results: Three phenotypes emerged—Thin‐Straight ( n = 638), Protrusive‐Convex ( n = 644) and Thick‐Concave ( n = 389)—showing broad correspondence with skeletal Classes I, II and III, respectively (Cramér's V = 0.386; overall concordance 52.8%). Lip protrusion and thickness were the primary discriminators (4/4 method consensus for UL_EP_mm, Cm_Sn_Ls, SSD; 3/4 for ULT). Within each skeletal class, all lip variables differed significantly across phenotypes (all p < 0.001; η 2 = 0.10–0.54 for lip variables), and lip phenotype independently predicted incisor inclination beyond skeletal covariates (Δ R 2 adj = 0.058–0.078, p < 0.001). An interpretable decision tree achieved 88.0% cross‐validated accuracy (macro‐F1 = 0.876) for phenotype assignment. Conclusions: Unsupervised learning identified three reproducible lip soft‐tissue phenotypes that complement conventional dentoskeletal description by capturing within‐class soft‐tissue heterogeneity. The framework is exploratory and requires prospective external validation and outcome‐based studies before clinical triage application.
- Open Access
- 27 February 2026
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 83 (1)
IMP2 enhances M2 macrophage polarization via LKB1-AMPK-mediated mitochondrial dynamics and fatty acid β-oxidation to ameliorate diabetic osteoporosis
The online version contains supplementary material available at 10.1007/s00018-026-06093-5.
- 27 February 2026
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 83 (1)
Open AccessIMP2 enhances M2 macrophage polarization via LKB1-AMPK-mediated mitochondrial dynamics and fatty acid β-oxidation to ameliorate diabetic osteoporosis
The online version contains supplementary material available at 10.1007/s00018-026-06093-5.
- Top Cited PapersOpen Access
- 26 January 2026
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 32 (1) , e70754
The Interface of Oral and Brain Health: Current Insights Into the Bidirectional Relationship Between Alzheimer's Disease and Periodontitis
Background: The bidirectional relationship between Alzheimer's disease (AD) and periodontitis highlights a critical interface between oral and brain health, increasingly recognized as a key axis in aging‐related degenerative diseases. This review synthesizes epidemiological, pathological, and mechanistic evidence underpinning their interconnected pathogenesis. Results and Conclusion: Epidemiologically, periodontitis is associated with an increased risk of AD, while AD patients exhibit a higher prevalence of periodontitis, driven by cognitive decline‐impaired oral hygiene and synergistic inflammatory mechanisms. Pathologically, periodontal pathogens (e.g., Porphyromonas gingivalis ) translocate to the brain via hematogenous, trigeminal, or oral‐intestinal pathways, inducing neuroinflammation, β‐amyloid (Aβ) aggregation, and tau hyperphosphorylation through virulence factors like gingipains and LPS. Conversely, AD‐related neurodegeneration disrupts bone homeostasis to aggravate periodontitis via multiple mechanisms: (1) Aβ‐mediated osteoclast activation through RAGE/NF‐κB signaling and suppression of osteoblastogenesis; (2) autonomic nervous system dysregulation, where sympathetic hyperactivity promotes RANKL‐dependent bone resorption; and (3) endocrine dysfunction, including HPA axis hyperactivation (chronic hypercortisolism), sex hormone deficiency, insulin resistance, and growth hormone/IGF‐1 insufficiency, all of which perturb the balance between bone formation and resorption. Aging exacerbates this bidirectional interplay through immunosenescence (e.g., impaired neutrophil phagocytosis, senescent microglia) and inflammaging, creating a pro‐degenerative milieu that amplifies both diseases. Clinical interventions, such as periodontal therapy and microbiota modulation, show promise in reducing systemic inflammation and slowing AD progression, though causal links require validation. Future research must prioritize longitudinal cohort studies, pathogen‐specific mechanistic investigations, and translational strategies targeting the oral‐brain axis to develop preventive interventions for aging populations.
- 26 January 2026
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 32 (1) , e70754
Top Cited PapersOpen AccessThe Interface of Oral and Brain Health: Current Insights Into the Bidirectional Relationship Between Alzheimer's Disease and Periodontitis
Background: The bidirectional relationship between Alzheimer's disease (AD) and periodontitis highlights a critical interface between oral and brain health, increasingly recognized as a key axis in aging‐related degenerative diseases. This review synthesizes epidemiological, pathological, and mechanistic evidence underpinning their interconnected pathogenesis. Results and Conclusion: Epidemiologically, periodontitis is associated with an increased risk of AD, while AD patients exhibit a higher prevalence of periodontitis, driven by cognitive decline‐impaired oral hygiene and synergistic inflammatory mechanisms. Pathologically, periodontal pathogens (e.g., Porphyromonas gingivalis ) translocate to the brain via hematogenous, trigeminal, or oral‐intestinal pathways, inducing neuroinflammation, β‐amyloid (Aβ) aggregation, and tau hyperphosphorylation through virulence factors like gingipains and LPS. Conversely, AD‐related neurodegeneration disrupts bone homeostasis to aggravate periodontitis via multiple mechanisms: (1) Aβ‐mediated osteoclast activation through RAGE/NF‐κB signaling and suppression of osteoblastogenesis; (2) autonomic nervous system dysregulation, where sympathetic hyperactivity promotes RANKL‐dependent bone resorption; and (3) endocrine dysfunction, including HPA axis hyperactivation (chronic hypercortisolism), sex hormone deficiency, insulin resistance, and growth hormone/IGF‐1 insufficiency, all of which perturb the balance between bone formation and resorption. Aging exacerbates this bidirectional interplay through immunosenescence (e.g., impaired neutrophil phagocytosis, senescent microglia) and inflammaging, creating a pro‐degenerative milieu that amplifies both diseases. Clinical interventions, such as periodontal therapy and microbiota modulation, show promise in reducing systemic inflammation and slowing AD progression, though causal links require validation. Future research must prioritize longitudinal cohort studies, pathogen‐specific mechanistic investigations, and translational strategies targeting the oral‐brain axis to develop preventive interventions for aging populations.
- 4 January 2026
- Published by Wiley in Oral Diseases
- Vol. 32 (4) , 1194-1195
Authors' Reply “Histochemical Assessment of Cementum and Alveolar Bone in SDT fa / fa Rat Mimicking Type II Diabetes”
- 4 January 2026
- Published by Wiley in Oral Diseases
- Vol. 32 (4) , 1194-1195
Authors' Reply “Histochemical Assessment of Cementum and Alveolar Bone in SDT fa / fa Rat Mimicking Type II Diabetes”